Free Trial

AdvanSix (NYSE:ASIX) Sets New 52-Week Low After Insider Selling

AdvanSix Inc. (NYSE:ASIX - Get Free Report)'s share price hit a new 52-week low during trading on Friday after an insider sold shares in the company. The stock traded as low as $22.34 and last traded at $23.08, with a volume of 86857 shares. The stock had previously closed at $25.75.Specifically, SVP Achilles B. Kintiroglou sold 4,000 shares of the business's stock in a transaction that occurred on Monday, April 1st. The stock was sold at an average price of $27.69, for a total transaction of $110,760.00. Following the completion of the transaction, the senior vice president now owns 38,996 shares in the company, valued at approximately $1,079,799.24. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other news, SVP Achilles B. Kintiroglou sold 4,000 shares of the firm's stock in a transaction on Monday, April 1st. The stock was sold at an average price of $27.69, for a total transaction of $110,760.00. Following the transaction, the senior vice president now directly owns 38,996 shares of the company's stock, valued at $1,079,799.24. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Erin N. Kane sold 5,000 shares of the business's stock in a transaction dated Thursday, March 28th. The stock was sold at an average price of $28.30, for a total transaction of $141,500.00. Following the sale, the chief executive officer now owns 557,755 shares in the company, valued at $15,784,466.50. The disclosure for this sale can be found here. In the last ninety days, insiders sold 21,048 shares of company stock worth $578,848. 5.20% of the stock is currently owned by insiders.

Analysts Set New Price Targets


Separately, Stifel Nicolaus reaffirmed a "buy" rating and issued a $40.00 price objective on shares of AdvanSix in a research note on Tuesday, April 9th.

Check Out Our Latest Stock Report on AdvanSix

AdvanSix Price Performance

The stock has a 50 day moving average of $27.06 and a two-hundred day moving average of $27.14. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.58 and a current ratio of 1.17. The stock has a market cap of $591.70 million, a PE ratio of 12.15 and a beta of 1.74.

AdvanSix (NYSE:ASIX - Get Free Report) last released its earnings results on Friday, February 16th. The company reported ($0.17) earnings per share for the quarter, topping the consensus estimate of ($0.19) by $0.02. AdvanSix had a net margin of 3.56% and a return on equity of 6.98%. The business had revenue of $382.21 million for the quarter, compared to the consensus estimate of $335.80 million. Equities analysts anticipate that AdvanSix Inc. will post 1.04 EPS for the current year.

AdvanSix Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, March 18th. Investors of record on Monday, March 4th were paid a $0.16 dividend. This represents a $0.64 annualized dividend and a yield of 2.90%. The ex-dividend date of this dividend was Friday, March 1st. AdvanSix's dividend payout ratio is currently 33.68%.

Hedge Funds Weigh In On AdvanSix

Several institutional investors and hedge funds have recently bought and sold shares of ASIX. Donald Smith & CO. Inc. purchased a new position in AdvanSix in the fourth quarter valued at about $4,191,000. Wellington Management Group LLP acquired a new position in AdvanSix in the third quarter worth approximately $4,081,000. Richard Bernstein Advisors LLC bought a new position in AdvanSix during the third quarter valued at approximately $2,370,000. Foundry Partners LLC lifted its stake in AdvanSix by 45.3% in the third quarter. Foundry Partners LLC now owns 135,634 shares of the company's stock valued at $4,216,000 after acquiring an additional 42,286 shares during the last quarter. Finally, Victory Capital Management Inc. grew its position in AdvanSix by 26.7% in the third quarter. Victory Capital Management Inc. now owns 2,177,830 shares of the company's stock worth $67,687,000 after acquiring an additional 458,622 shares in the last quarter. Hedge funds and other institutional investors own 86.39% of the company's stock.

About AdvanSix

(Get Free Report)

AdvanSix Inc engages in the manufacture and sale of polymer resins in the United States and internationally. It offers Nylon 6, a polymer resin, which is a synthetic material used to produce fibers, filaments, engineered plastics, and films. The company also provides caprolactam to manufacture polymer resins; ammonium sulfate fertilizers to distributors, farm cooperatives, and retailers; and acetone that are used in the production of adhesives, paints, coatings, solvents, herbicides, and engineered plastic resins, as well as other intermediate chemicals, including phenol, monoisopropylamine, dipropylamine, monoallylamine, alpha-methylstyrene, cyclohexanone, methyl ethyl ketoxime, acetaldehyde oxime, 2-pentanone oxime, cyclohexanol, sulfuric acid, ammonia, and carbon dioxide.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should you invest $1,000 in AdvanSix right now?

Before you consider AdvanSix, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AdvanSix wasn't on the list.

While AdvanSix currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Featured Articles and Offers

Biotech Boom: Stocks Skyrocketing & What's Next

Biotech Boom: Stocks Skyrocketing & What's Next

Dive into biotech's latest trends with Dylan Jovine: weight loss breakthroughs, smart chemo innovations, and expert stock evaluation tips.

Search Headlines: